Eng C - Search Results

1

Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.

Gimm O, Marsh DJ, Andrew SD, Frilling A, Dahia PL, Mulligan LM, Zajac JD, Robinson BG, Eng C. Gimm O, et al. Among authors: eng c. J Clin Endocrinol Metab. 1997 Nov;82(11):3902-4. doi: 10.1210/jcem.82.11.4508. J Clin Endocrinol Metab. 1997. PMID: 9360560

2

Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.

Myers SM, Eng C, Ponder BA, Mulligan LM. Myers SM, et al. Among authors: eng c. Oncogene. 1995 Nov 16;11(10):2039-45. Oncogene. 1995. PMID: 7478523

3

Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.

Frilling A, Dralle H, Eng C, Raue F, Broelsch CE. Frilling A, et al. Among authors: eng c. Surgery. 1995 Dec;118(6):1099-103; discussion 1103-4. doi: 10.1016/s0039-6060(05)80120-5. Surgery. 1995. PMID: 7491529

4

Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Pfragner R, Behmel A, Lorenzo MJ, et al. Eng C, et al. Genes Chromosomes Cancer. 1995 Mar;12(3):209-12. doi: 10.1002/gcc.2870120308. Genes Chromosomes Cancer. 1995. PMID: 7536460

5

Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.

Neumann HP, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BA, Crossey PA, Maher ER, Brauch H. Neumann HP, et al. Among authors: eng c. JAMA. 1995 Oct 11;274(14):1149-51. JAMA. 1995. PMID: 7563486

6

Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

Attié T, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, Nihoul-Fékété C, Munnich A, et al. Attié T, et al. Among authors: eng c. Hum Mol Genet. 1995 Aug;4(8):1381-6. doi: 10.1093/hmg/4.8.1381. Hum Mol Genet. 1995. PMID: 7581377

7

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Ponder MA, Ponder BA. Eng C, et al. Clin Endocrinol (Oxf). 1995 Jul;43(1):123-7. doi: 10.1111/j.1365-2265.1995.tb01903.x. Clin Endocrinol (Oxf). 1995. PMID: 7641404

8

Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.

Frilling A, Höppner W, Eng C, Mulligan L, Raue F, Broelsch CE. Frilling A, et al. Among authors: eng c. J Mol Med (Berl). 1995 May;73(5):229-33. doi: 10.1007/BF00189922. J Mol Med (Berl). 1995. PMID: 7670926

9

Multiple mRNA isoforms of the human RET proto-oncogene generated by alternate splicing.

Lorenzo MJ, Eng C, Mulligan LM, Stonehouse TJ, Healey CS, Ponder BA, Smith DP. Lorenzo MJ, et al. Among authors: eng c. Oncogene. 1995 Apr 6;10(7):1377-83. Oncogene. 1995. PMID: 7731689

10

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling.

Songyang Z, Carraway KL 3rd, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, et al. Songyang Z, et al. Among authors: eng c. Nature. 1995 Feb 9;373(6514):536-9. doi: 10.1038/373536a0. Nature. 1995. PMID: 7845468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,902 results

Search Page

Filters